Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

People with severe Alopecia Areata have higher levels of TGF-β1, which may play a role in the condition.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Low vitamin D levels are linked to severe and active alopecia areata.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

The patch effectively promotes hair growth for alopecia areata without pain.

Pumpkin seed oil may help hair growth, but more research needed on frontal hair loss and long-term effects.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

The conference discussed various hair disorders and treatments, including the use of topical steroids, high doses of cetrizine, and hair grafting, as well as the psychological impact of hair loss.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

The microbiome may be linked to hair loss and could be a target for new treatments.